These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease. Meng C; Lin H; Huang J; Wang H; Cai Q; Fang L; Guo Y Microb Pathog; 2009 Sep; 47(3):151-6. PubMed ID: 19467319 [TBL] [Abstract][Full Text] [Related]
6. Intranasal Immunization with the Commensal Shekhar S; Khan R; Schenck K; Petersen FC Appl Environ Microbiol; 2019 Mar; 85(6):. PubMed ID: 30683742 [No Abstract] [Full Text] [Related]
13. Peptide mimics of two pneumococcal capsular polysaccharide serotypes (6B and 9V) protect mice from a lethal challenge with Streptococcus pneumoniae. Smith CM; Lo Passo C; Scuderi A; Kolberg J; Baxendale H; Goldblatt D; Oggioni MR; Felici F; Andrew PW Eur J Immunol; 2009 Jun; 39(6):1527-35. PubMed ID: 19499518 [TBL] [Abstract][Full Text] [Related]
14. Production, binding characteristics and protective immunity of monoclonal antibody to pneumococcal type-9V conjugate. Lee CJ; Karpas A; Wang TR; Kosaka T; Koizumi K Microbiol Immunol; 1996; 40(11):857-65. PubMed ID: 8985941 [TBL] [Abstract][Full Text] [Related]
15. [Effect of strain-producer and cultivation medium on cross antigenic activity of Streptococcus pneumoniae water soluble antigens]. Kurbatova EA; Vorob'ev DS; Egorova NB; Elkina SI; Kalina NG; Tokarskaia MM; Baturo AP; Romanenko ÉE; Markova ME; Grishchenko NV; Ovechko NN; Volokh IuV; Zlygostev SA; Mikhaĭlova NA Zh Mikrobiol Epidemiol Immunobiol; 2013; (1):26-33. PubMed ID: 23805648 [TBL] [Abstract][Full Text] [Related]
16. The Pneumococcal Serotype 15C Capsule Is Partially O-Acetylated and Allows for Limited Evasion of 23-Valent Pneumococcal Polysaccharide Vaccine-Elicited Anti-Serotype 15B Antibodies. Spencer BL; Shenoy AT; Orihuela CJ; Nahm MH Clin Vaccine Immunol; 2017 Aug; 24(8):. PubMed ID: 28637806 [TBL] [Abstract][Full Text] [Related]
17. Conjugation of PspA4Pro with Capsular Streptococcus pneumoniae Polysaccharide Serotype 14 Does Not Reduce the Induction of Cross-Reactive Antibodies. da Silva MA; Converso TR; Gonçalves VM; Leite LCC; Tanizaki MM; Barazzone GC Clin Vaccine Immunol; 2017 Aug; 24(8):. PubMed ID: 28637805 [TBL] [Abstract][Full Text] [Related]
18. Development of a conjugate vaccine against invasive pneumococcal disease based on capsular polysaccharides coupled with PspA/family 1 protein of Streptococcus pneumoniae. Lin H; Peng Y; Lin Z; Zhang S; Guo Y Microb Pathog; 2015; 83-84():35-40. PubMed ID: 25959527 [TBL] [Abstract][Full Text] [Related]
19. The potential for using protein vaccines to protect against otitis media caused by Streptococcus pneumoniae. Briles DE; Hollingshead SK; Nabors GS; Paton JC; Brooks-Walter A Vaccine; 2000 Dec; 19 Suppl 1():S87-95. PubMed ID: 11163470 [TBL] [Abstract][Full Text] [Related]
20. Immunogenicity and mechanisms of action of PnuBioVax, a multi-antigen serotype-independent prophylactic vaccine against infection with Streptococcus pneumoniae. Hill S; Entwisle C; Pang Y; Joachim M; McIlgorm A; Dalton K; Burbidge P; Colaco C; Brown J; Goldblatt D; Bailey C Vaccine; 2018 Jul; 36(29):4255-4264. PubMed ID: 29895498 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]